Pharma and Biotech
By Sean Farrell
Date: Thursday 15 Jul 2021
(Sharecast News) - Nuformix's annual loss widened as revenue fell and the pharmaceutical company spent to development its treatments.
By Sean Farrell
Date: Wednesday 10 Feb 2021
(Sharecast News) - Chris Blackwell has quit as Nuformix's chairman a year after taking the job at the drug development company.
By Josh White
Date: Thursday 18 Jul 2019
(Sharecast News) - Nuformix reported total revenue of £0.61m in its final results on Thursday, rising from £0.02m in the prior year, with the company swinging to a gross profit of £0.07m, from a loss of £0.19m.
Currency | UK Pounds |
Share Price | 0.088p |
Change Today | 0.008p |
% Change | 9.38 % |
52 Week High | 0.22 |
52 Week Low | 0.048 |
Volume | 131,085,626 |
Shares Issued | 1,669.31m |
Market Cap | £1.46m |
Beta | 0.28 |
RiskGrade | 322 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:29 | 421,602 @ 0.093p |
16:28 | 3,000,000 @ 0.085p |
16:28 | 255,899 @ 0.092p |
16:23 | 2,000,000 @ 0.089p |
15:21 | 10,000,000 @ 0.085p |
You are here: research